Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
And then we have, as you always do, the odd real disappointment. And in this...
— Thomas Coutts / Brian Lum / Julia Angeles / Lawrence Burns / Robert Wilson
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Genmab A/S
No other institutional pitches found for this ticker yet.
More institutional theses from Baillie Gifford -International Growth
The manager remains highly optimistic about WiseTech despite recent governance issues that have caused share price weakness. While some colleagues...
ASML's recent stock weakness is viewed as cyclical noise inherent to the volatile semiconductor sector rather than a fundamental issue. The manager maintains...
Pinduoduo is cited as one of the strong-performing Chinese holdings that have delivered excellent operational performance. The company has...